Diseases & Disorders
(G45)
IRS Verified
DX Registered
990 on File
PULMONARY FIBROSIS FOUNDATION
Financial strength (30%)
74/100
Reliability (20%)
55/100
Effectiveness (25%)
75/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$9.3M
Total Revenue
$7.4M
Total Expenses
$13.7M
Net Assets
39
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
67.1%
Fundraising Efficiency
4018.8%
Operating Reserve
22.32x
Liability-to-Asset
21.5%
Revenue Diversification
86.4%
Executive Compensation
$874K
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
67.1% | 83.2% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
17.3% | 11.0% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
15.5% | 2.5% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
4018.8% | 112.2% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
22.3 mo | 12.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
21.5% | 12.5% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
86.4% | 87.6% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
11.8% | 7.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-18.2% | 5.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
20.3% | 4.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $9.3M | $7.4M | $13.7M | 67.1% | 39 |
| 2024 | $8.3M | $9.0M | $11.5M | 76.9% | 43 |
| 2023 | $11.8M | $10.3M | $11.7M | 74.7% | 42 |
| 2022 | $11.0M | $9.7M | $10.0M | 74.3% | 41 |
| 2021 | $15.6M | $8.3M | N/A | — | 39 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.